| Product Code: ETC13365220 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Personalized Medicine Outsourcing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Personalized Medicine Outsourcing Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Personalized Medicine Outsourcing Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Personalized Medicine Outsourcing Market - Industry Life Cycle |
3.4 Europe Personalized Medicine Outsourcing Market - Porter's Five Forces |
3.5 Europe Personalized Medicine Outsourcing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Personalized Medicine Outsourcing Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.7 Europe Personalized Medicine Outsourcing Market Revenues & Volume Share, By Therapy Area, 2021 & 2031F |
3.8 Europe Personalized Medicine Outsourcing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Europe Personalized Medicine Outsourcing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.10 Europe Personalized Medicine Outsourcing Market Revenues & Volume Share, By Contract Model, 2021 & 2031F |
4 Europe Personalized Medicine Outsourcing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Personalized Medicine Outsourcing Market Trends |
6 Europe Personalized Medicine Outsourcing Market, 2021 - 2031 |
6.1 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Drug Discovery, 2021 - 2031 |
6.1.3 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Genomic Analysis, 2021 - 2031 |
6.1.4 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Biomarker Development, 2021 - 2031 |
6.1.5 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Clinical Trials, 2020 - 2028 |
6.1.6 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Regulatory Compliance, 2020 - 2028 |
6.2 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Therapy Area, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.2.3 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Neurology, 2021 - 2031 |
6.2.4 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Cardiology, 2021 - 2031 |
6.2.5 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Endocrinology, 2021 - 2031 |
6.2.6 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Immunology, 2020 - 2028 |
6.3 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Pharma Companies, 2021 - 2031 |
6.3.3 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Biotech Firms, 2021 - 2031 |
6.3.4 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Research Institutes, 2021 - 2031 |
6.3.5 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.6 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Government Bodies, 2021 - 2031 |
6.4 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By AI-Powered Drug Development, 2021 - 2031 |
6.4.3 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Next-Gen Sequencing, 2021 - 2031 |
6.4.4 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By CRISPR Gene Editing, 2020 - 2028 |
6.4.5 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Personalized Drug Formulation, 2020 - 2028 |
6.4.6 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Bioprinting, 2020 - 2028 |
6.5 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Contract Model, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Full-Service, 2020 - 2028 |
6.5.3 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Fee-for-Service, 2020 - 2028 |
6.5.4 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Hybrid, 2020 - 2028 |
6.5.5 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Pay-Per-Use, 2020 - 2028 |
6.5.6 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Subscription, 2020 - 2028 |
7 Europe Personalized Medicine Outsourcing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.1 United Kingdom (UK) Personalized Medicine Outsourcing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.2 Germany Personalized Medicine Outsourcing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.3 France Personalized Medicine Outsourcing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.4 Poland Personalized Medicine Outsourcing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.5 Spain Personalized Medicine Outsourcing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.2.6 Rest of Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Service Type, 2021 - 2031 |
7.3 Europe Personalized Medicine Outsourcing Market Revenues & Volume Share, By Therapy Area, 2021 & 2031F |
7.3.1 United Kingdom (UK) Personalized Medicine Outsourcing Market, Revenues & Volume, By Therapy Area, 2021 - 2031 |
7.3.2 Germany Personalized Medicine Outsourcing Market, Revenues & Volume, By Therapy Area, 2021 - 2031 |
7.3.3 France Personalized Medicine Outsourcing Market, Revenues & Volume, By Therapy Area, 2021 - 2031 |
7.3.4 Poland Personalized Medicine Outsourcing Market, Revenues & Volume, By Therapy Area, 2021 - 2031 |
7.3.5 Spain Personalized Medicine Outsourcing Market, Revenues & Volume, By Therapy Area, 2021 - 2031 |
7.3.6 Rest of Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Therapy Area, 2021 - 2031 |
7.4 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.1 United Kingdom (UK) Personalized Medicine Outsourcing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.2 Germany Personalized Medicine Outsourcing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.3 France Personalized Medicine Outsourcing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.4 Poland Personalized Medicine Outsourcing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.5 Spain Personalized Medicine Outsourcing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.6 Rest of Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.1 United Kingdom (UK) Personalized Medicine Outsourcing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.2 Germany Personalized Medicine Outsourcing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.3 France Personalized Medicine Outsourcing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.4 Poland Personalized Medicine Outsourcing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.5 Spain Personalized Medicine Outsourcing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.5.6 Rest of Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.6 Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Contract Model, 2021 - 2031 |
7.6.1 United Kingdom (UK) Personalized Medicine Outsourcing Market, Revenues & Volume, By Contract Model, 2021 - 2031 |
7.6.2 Germany Personalized Medicine Outsourcing Market, Revenues & Volume, By Contract Model, 2021 - 2031 |
7.6.3 France Personalized Medicine Outsourcing Market, Revenues & Volume, By Contract Model, 2021 - 2031 |
7.6.4 Poland Personalized Medicine Outsourcing Market, Revenues & Volume, By Contract Model, 2021 - 2031 |
7.6.5 Spain Personalized Medicine Outsourcing Market, Revenues & Volume, By Contract Model, 2021 - 2031 |
7.6.6 Rest of Europe Personalized Medicine Outsourcing Market, Revenues & Volume, By Contract Model, 2021 - 2031 |
8 Europe Personalized Medicine Outsourcing Market Key Performance Indicators |
9 Europe Personalized Medicine Outsourcing Market - Export/Import By Countries Assessment |
10 Europe Personalized Medicine Outsourcing Market - Opportunity Assessment |
10.1 Europe Personalized Medicine Outsourcing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Personalized Medicine Outsourcing Market Opportunity Assessment, By Service Type, 2021 & 2031F |
10.3 Europe Personalized Medicine Outsourcing Market Opportunity Assessment, By Therapy Area, 2021 & 2031F |
10.4 Europe Personalized Medicine Outsourcing Market Opportunity Assessment, By End User, 2021 & 2031F |
10.5 Europe Personalized Medicine Outsourcing Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.6 Europe Personalized Medicine Outsourcing Market Opportunity Assessment, By Contract Model, 2021 & 2031F |
11 Europe Personalized Medicine Outsourcing Market - Competitive Landscape |
11.1 Europe Personalized Medicine Outsourcing Market Revenue Share, By Companies, 2022 |
11.2 Europe Personalized Medicine Outsourcing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here